Aimee E. Houlton
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Chronic Myeloid Leukemia Treatments, Histone Deacetylase Inhibitors Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Acute Ischemic Stroke Management
Most-Cited Works
- → Ruxolitinib vs best available therapy for ET intolerant or resistant to hydroxycarbamide(2017)165 cited
- → Outcome of Azacitidine Therapy in Acute Myeloid Leukemia Is not Improved by Concurrent Vorinostat Therapy but Is Predicted by a Diagnostic Molecular Signature(2017)85 cited
- → Beta-hydroxy beta-methylbutyrate/arginine/glutamine (HMB/Arg/Gln) supplementation to improve the management of cachexia in patients with advanced lung cancer: an open-label, multicentre, randomised, controlled phase II trial (NOURISH)(2021)78 cited
- → Performance characteristics of methods for quantifying spontaneous intracerebral haemorrhage: data from the Efficacy of Nitric Oxide in Stroke (ENOS) trial(2015)40 cited
- → Prognostic value of monitoring a candidate immunophenotypic leukaemic stem/progenitor cell population in patients allografted for acute myeloid leukaemia(2014)34 cited
- → Patient-Reported Outcomes After Extensive (Ultraradical) Surgery for Ovarian Cancer(2015)29 cited
- → A phase II study to assess the safety and efficacy of the dual mTORC1/2 inhibitor vistusertib in relapsed, refractory DLBCL(2019)24 cited
- → Statistical Analysis Plan for the ‘Efficacy of Nitric Oxide in Stroke’ (ENOS) Trial(2014)24 cited
- → PEPtalk2: results of a pilot randomised controlled trial to compare VZIG and aciclovir as postexposure prophylaxis (PEP) against chickenpox in children with cancer(2018)12 cited
- MOLECULAR PREDICTORS OF RESPONSE TO AZACITIDINE THERAPY: THE RESULTS OF THE UK TRIALS ACCELERATION PROGRAMME RAVVA STUDY(2017)